JPS5933218A - 抗マイコバクテリア組成物 - Google Patents

抗マイコバクテリア組成物

Info

Publication number
JPS5933218A
JPS5933218A JP58135265A JP13526583A JPS5933218A JP S5933218 A JPS5933218 A JP S5933218A JP 58135265 A JP58135265 A JP 58135265A JP 13526583 A JP13526583 A JP 13526583A JP S5933218 A JPS5933218 A JP S5933218A
Authority
JP
Japan
Prior art keywords
culture
leprosy
pharmaceutical composition
pyrimidine
cyami
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58135265A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0419968B2 (de
Inventor
ヨアヒム・カルル・ザイデル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5933218A publication Critical patent/JPS5933218A/ja
Publication of JPH0419968B2 publication Critical patent/JPH0419968B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58135265A 1982-07-29 1983-07-26 抗マイコバクテリア組成物 Granted JPS5933218A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4600/82A CH651473A5 (de) 1982-07-29 1982-07-29 Pharmazeutisches praeparat.
CH4600/82-8 1982-07-29

Publications (2)

Publication Number Publication Date
JPS5933218A true JPS5933218A (ja) 1984-02-23
JPH0419968B2 JPH0419968B2 (de) 1992-03-31

Family

ID=4279115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58135265A Granted JPS5933218A (ja) 1982-07-29 1983-07-26 抗マイコバクテリア組成物

Country Status (8)

Country Link
JP (1) JPS5933218A (de)
BE (1) BE897397A (de)
CH (1) CH651473A5 (de)
DE (1) DE3326165A1 (de)
FR (1) FR2531861B1 (de)
GB (1) GB2125293B (de)
IT (1) IT1171692B (de)
NL (1) NL194535C (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK387687A (da) * 1986-07-28 1988-01-29 Warner Lambert Co Fremstilling af farmaceutisk praeparat til behandling af infektioner med mycobacterium avium-intracellulare komplekset

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE419444B (sv) * 1973-11-08 1981-08-03 Hoffmann La Roche Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
ZW10681A1 (en) * 1980-06-26 1982-02-24 Hoffmann La Roche Antibacterial agents
GB2082063A (en) * 1980-08-15 1982-03-03 Haughey Edward Antibacterial drug

Also Published As

Publication number Publication date
DE3326165C2 (de) 1993-07-22
GB2125293A (en) 1984-03-07
DE3326165A1 (de) 1984-04-12
JPH0419968B2 (de) 1992-03-31
GB8320438D0 (en) 1983-09-01
IT1171692B (it) 1987-06-10
NL8302579A (nl) 1984-02-16
BE897397A (fr) 1984-01-30
NL194535C (nl) 2002-07-02
FR2531861B1 (fr) 1987-08-28
NL194535B (nl) 2002-03-01
FR2531861A1 (fr) 1984-02-24
CH651473A5 (de) 1985-09-30
GB2125293B (en) 1985-11-13
IT8322089A0 (it) 1983-07-15
IT8322089A1 (it) 1985-01-15

Similar Documents

Publication Publication Date Title
KR100230514B1 (ko) 산화질소 형성 또는 내피 유도 이완 인자와 관련된 전신적 저혈압을 억제하기 위한 아르기닌 길항제
JP5409710B2 (ja) 心肺バイパス（ｃｐｂ）手術の術後合併症を低減するための組成物
KR880011199A (ko) 신규 펩타이드 화합물, 그의 제조방법 및 그를 함유하는 약학적 조성물
JP2011225610A (ja) Ｎ−アセチルシステイン組成物及び薬剤毒性治療または防止方法
CN104812394B (zh) 吩噻嗪衍生物及其治疗肺结核的用途
JPS60105618A (ja) 毒血症と闘うための組成物
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
EP1369119B1 (de) Mittel zur steurung der expression von il-12
TW434012B (en) Pharmaceutical composition for treating airway diseases in mammals
Takeuchi et al. Inhibition of lung natural killer cell activity by smoking: the role of alveolar macrophages
Brodie et al. Observations on G-25671, A Phenylbutazone Analogue (4-(phenylthioethyl)− 1, 2-diphenyl 3, 5-pyrazolidinedione).
ATUK et al. The use of potentially nephrotoxic antibiotics in the treatment of gram-negative infections in uremic patients
JPH07506804A (ja) 痴呆の処置のためのダプソーン及びプロミン
JP2515119B2 (ja) ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物
Miller et al. Fatal agranulocytosis resulting from a procaine derivative
JPH06503806A (ja) 胃腸疾病を処置するための５―ジフルオロメトキシ―２―［（３，４―ジメトキシ―２―ピリジル）メチルスルフィニル］ベンズイミダゾール及び抗ヘリコバクター剤含有医薬組成物
Lawrence Bacteriostatic Actions of Three Thiazol Derivatives of Sulfanila-mide upon Bacteria in Broth Cultures
CN1204881C (zh) 烯丙胺衍生物在制备治疗幽门螺杆菌感染和相关疾病的药物方面的用途
JPH072672A (ja) 抗菌性配合製剤
FLINN et al. Para-aminobenzoic acid treatment of Rocky Mountain spotted fever
Kosmidis et al. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection
Steenken Jr et al. Further observations on pyrazinamide alone and in combination with other drugs in experimental tuberculosis
JPH0419968B2 (de)
Olsen et al. Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia
Adibi et al. Synthesis and characterization of hydrazide-hydrazone derivatives of 3-pyridine carboxylic acid as antimycobacterial tuberculosis agents